Publication | Closed Access

Three‐year Open Protocol Continuation Study of Oral Tolerization with Myelin Antigens in Multiple Sclerosis and Design of a Phase III Pivotal Trial

Neurological DisorderMedicineImmunologyClinical TrialsMyelin AntigensClinical NeurologyNeurological ProgressNeurologyMultiple SclerosisImmunotherapyNeuroimmunologyOral Tolerization